pharmavoice
The clinical development marketplace continues to become more complex and competitive, with stricter regulatory standards and trial oversight—all the while demanding patient-centric drug development. These, and other factors, contribute to unsustainable costs and longer timelines before much-needed therapies reach the market.
Watch Now
Pistoia Alliance
This talk presents an overview of the philosophy and ongoing work of the PhUSE project "Clinical Trials Results as Resource Description Framework." The team is converting data from the CDISC Study Data Tabulation Model (SDTM) to graph data using an ontology-based approach. The wider implications of this work are discussed, along with deployment strategies within and beyond the industry.
Watch Now
questexweb
Biopharmaceutical companies are increasingly challenged to create a drug pricing strategy that both rewards value and innovation, and promotes affordability and access. During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues, including:
Watch Now
xtalks
Many standard of care (SOC) treatments in cancer patients result in a clinical outcome of non-response. Drug development companies are trending toward interrogating resistance mechanisms and using this information in advancing their programs and informing personalized approaches to novel therapeutics.
Watch Now